Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$72.62 - $79.98 $1.55 Million - $1.7 Million
-21,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $1.31 Million - $1.57 Million
21,300 New
21,300 $1.56 Million
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $31.3 Million - $36.5 Million
-584,451 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $6.34 Million - $7.42 Million
-107,104 Reduced 15.49%
584,451 $34.6 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $2.78 Million - $3.03 Million
-44,981 Reduced 6.11%
691,555 $46.2 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $8.78 Million - $9.87 Million
-147,929 Reduced 16.73%
736,536 $46.5 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $415,323 - $470,637
7,193 Added 0.82%
884,465 $54.8 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $3.96 Million - $4.39 Million
68,991 Added 8.54%
877,272 $52.5 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $1.77 Million - $2.07 Million
32,226 Added 4.15%
808,281 $46.7 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $4.66 Million - $6.77 Million
-100,448 Reduced 11.46%
776,055 $42.2 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $14.2 Million - $18.5 Million
288,360 Added 49.03%
876,503 $55.9 Million
Q3 2019

Nov 13, 2019

SELL
$42.77 - $50.71 $8 Million - $9.48 Million
-187,035 Reduced 24.13%
588,143 $29.5 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $5.84 Million - $6.46 Million
-130,876 Reduced 14.44%
775,178 $35 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $3.57 Million - $4.26 Million
-79,182 Reduced 8.04%
906,054 $43.3 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $4.27 Million - $5.53 Million
87,513 Added 9.75%
985,236 $50.2 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $3.89 Million - $4.38 Million
-70,403 Reduced 7.27%
897,723 $55.6 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $14.5 Million - $18.1 Million
287,159 Added 42.17%
968,126 $53.6 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $9.47 Million - $10.9 Million
-158,060 Reduced 18.84%
680,967 $42.6 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $2.26 Million - $2.46 Million
37,702 Added 4.7%
839,027 $51.4 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $9.72 Million - $11.2 Million
175,983 Added 28.14%
801,325 $51.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
625,342
625,342 $34.9 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.